Scarica l'app Stockscreener
87.59
2.07%
-1.85
Dopo l'orario di chiusura:
87.28
-0.31
-0.35%
Precedente Chiudi:
$89.44
Aprire:
$89.44
Volume 24 ore:
160.97K
Relative Volume:
1.29
Capitalizzazione di mercato:
$4.01B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+7.03%
1M Prestazione:
-16.31%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$85.45
$89.74
Intervallo di 1 settimana:
$83.00
$100.00
Portata 52W:
$80.51
$138.70
Billiontoone Inc Stock (BLLN) Company Profile
Nome
Billiontoone Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta BLLN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BLLN
Billiontoone Inc
|
87.59 | 4.09B | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
606.50 | 231.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.00 | 166.39B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
712.39 | 57.06B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
243.19 | 41.60B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
145.76 | 41.90B | 6.95B | 1.30B | 1.15B | 4.5696 |
Billiontoone Inc Stock (BLLN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-06 | Iniziato | Guggenheim | Buy |
| 2025-12-01 | Iniziato | BTIG Research | Buy |
| 2025-12-01 | Iniziato | JP Morgan | Overweight |
| 2025-12-01 | Iniziato | Jefferies | Hold |
| 2025-12-01 | Iniziato | Piper Sandler | Overweight |
| 2025-12-01 | Iniziato | Stifel | Buy |
| 2025-12-01 | Iniziato | Wells Fargo | Equal Weight |
| 2025-12-01 | Iniziato | William Blair | Outperform |
Mostra tutto
Billiontoone Inc Borsa (BLLN) Ultime notizie
January 2026's Top Growth Companies With Insider Confidence - Yahoo Finance
BillionToOne, Inc. Announces Selection of Northstar Select as New Liquid Biopsy Test for LC-SCRUM-TRY Clinical Study at National Cancer Center Hospital East - MarketScreener
BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East - PR Newswire
3 Stocks Estimated To Be Up To 48.4% Below Intrinsic Value - Yahoo Finance
BillionToOne (BLLN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
BillionToOne Earnings Notes - Trefis
Med-tech IPOs shoot for the stars in 2025 - BioWorld MedTech
BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference - 富途牛牛
BillionToOne stock in focus before Monday open after Friday jump, JPMorgan conference next - ts2.tech
BillionToOne (BLLN) Stock Update: Friday Rally, Analyst Price Targets, and the Next Catalysts Before Nasdaq Reopens - ts2.tech
BillionToOne Stock (NASDAQ: BLLN) News: Weekend Market Wrap, Analyst Targets, and What to Watch Before Monday’s Open - ts2.tech
BillionToOne Stock (NASDAQ: BLLN) Rises Into the Weekend as Analyst Targets Point Higher — What Investors Need to Know Before Monday - ts2.tech
Should I buy BillionToOne, Inc. (BLLN) - Zacks Investment Research
Evommune and BillionToOne climb on trading debut - MSN
BillionToOne (BLLN) Is Down 6.7% After Joining the S&P Total Market IndexWhat's Changed - simplywall.st
BillionToOne falls -5.5% - MSN
BillionToOne: An Interesting Set-Up Into 2026 - Seeking Alpha
BillionToOne Stock (NASDAQ: BLLN) News, Forecasts, and Analyst Outlook for December 22, 2025 - ts2.tech
BillionToOne Adds Genmab CFO Anthony Pagano to Board, Names Him Audit Chair - TipRanks
Analysts Are Bullish on These Healthcare Stocks: Gilead Sciences (GILD), BillionToOne, Inc. Class A (BLLN) - The Globe and Mail
BillionToOne’s Earnings Call: Strong Growth and Strategic Outlook - TipRanks
BillionToOne, Inc. (NASDAQ:BLLN) Q3 2025 earnings call transcript - MSN
symbol__ Stock Quote Price and Forecast - CNN
Transcript : BillionToOne, Inc., Q3 2025 Earnings Call, Dec 09, 2025 - marketscreener.com
November reignites med-tech momentum with $4.7B raised - BioWorld MedTech
These Bay Area companies are IPO contenders in 2026 - The Business Journals
BillionToOne, Inc.: Strong Financial Performance and Strategic Market Positioning Drive Buy Rating - TipRanks
BillionToOne (BLLN) Revenue Surge Tests Bullish Growth Narrative Despite Ongoing EPS Losses - Sahm
BillionToOne, Inc.: Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating - TipRanks
BillionToOne, Inc. SEC 10-Q Report - TradingView — Track All Markets
BillionToOne price target lowered to $145 from $150 at JPMorgan - MSN
BillionToOne stock rating reiterated at Overweight by Piper Sandler - Investing.com South Africa
Jim Cramer Says BillionToOne Has a “Fantastic Story” Within the Diagnostics Space - MSN
BillionToOne Swings To Profit In Q3; Sees Q4 Revenue Soaring Up To 100% - Nasdaq
BillionToOne’s Strong Growth Potential and Strategic Integration Drive Buy Rating - TipRanks
BTIG Reiterates 'Buy' Rating for BillionToOne (BLLN) with PT of $160 | BLLN Stock News - GuruFocus
Earnings call transcript: BillionToOne’s strong Q3 2025 lifts stock 3.19% By Investing.com - Investing.com Nigeria
Billiontoone Q3 2025 Earnings Call Transcript - MarketBeat
BillionToOne Q3 2025 presentation slides: Revenue soars 117% as profitability achieved - Investing.com Canada
Earnings call transcript: BillionToOne’s strong Q3 2025 lifts stock 3.19% - Investing.com
Earnings call transcript: BillionToOne's strong Q3 2025 lifts stock 3.19% - Investing.com
BillionToOne appoints Genmab CFO Anthony Pagano to board - Investing.com
BillionToOne sees Q4 revenue $84M-$90M, consensus $80.14M - TipRanks
BillionToOne Appoints Anthony Pagano as Audit Chair - TipRanks
BillionToOne Q3 Swings to Profit, Revenue Rises; Shares Fall After Hours - marketscreener.com
Billiontoone Inc Azioni (BLLN) Dati Finanziari
Non sono disponibili dati finanziari per Billiontoone Inc (BLLN). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.37%
2.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):